These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15140578)

  • 21. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P
    Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics and complement in atypical HUS.
    Kavanagh D; Goodship T
    Pediatr Nephrol; 2010 Dec; 25(12):2431-42. PubMed ID: 20526633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
    Köse O; Zimmerhackl LB; Jungraithmayr T; Mache C; Nürnberger J
    Semin Thromb Hemost; 2010 Sep; 36(6):669-72. PubMed ID: 20865644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
    Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
    Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
    Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
    Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HUS and the case for complement.
    Conway EM
    Blood; 2015 Oct; 126(18):2085-90. PubMed ID: 26396094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome.
    Sánchez-Corral P; Pérez-Caballero D; Huarte O; Simckes AM; Goicoechea E; López-Trascasa M; de Córdoba SR
    Am J Hum Genet; 2002 Dec; 71(6):1285-95. PubMed ID: 12424708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
    Heinen S; Sanchez-Corral P; Jackson MS; Strain L; Goodship JA; Kemp EJ; Skerka C; Jokiranta TS; Meyers K; Wagner E; Robitaille P; Esparza-Gordillo J; Rodriguez de Cordoba S; Zipfel PF; Goodship TH
    Hum Mutat; 2006 Mar; 27(3):292-3. PubMed ID: 16470555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent microangiopathic hemolysis after recovery from complement-mediated hemolytic uremia syndrome during chemotherapy for a CFH-mutated patient with T-lymphoblastic lymphoma.
    Lee FW; Lee CY; Hung GY; Tseng MH; Wang HH; Yen HJ
    Int J Hematol; 2022 Nov; 116(5):812-818. PubMed ID: 35790695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Hematol; 2010 Sep; 17(5):432-8. PubMed ID: 20613506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human complement factor H deficiency associated with hemolytic uremic syndrome.
    Rougier N; Kazatchkine MD; Rougier JP; Fremeaux-Bacchi V; Blouin J; Deschenes G; Soto B; Baudouin V; Pautard B; Proesmans W; Weiss E; Weiss L
    J Am Soc Nephrol; 1998 Dec; 9(12):2318-26. PubMed ID: 9848786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.
    Le Quintrec M; Roumenina L; Noris M; Frémeaux-Bacchi V
    Semin Thromb Hemost; 2010 Sep; 36(6):641-52. PubMed ID: 20865641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.
    Pérez-Caballero D; González-Rubio C; Gallardo ME; Vera M; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Am J Hum Genet; 2001 Feb; 68(2):478-84. PubMed ID: 11170895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
    Ståhl AL; Vaziri-Sani F; Heinen S; Kristoffersson AC; Gydell KH; Raafat R; Gutierrez A; Beringer O; Zipfel PF; Karpman D
    Blood; 2008 Jun; 111(11):5307-15. PubMed ID: 18268093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
    Johnson SA; Williams JM; Hakobyan S; Richards A; Perkins SJ; Marchbank KJ; Goodship TH; Morgan BP; Taylor CM; Savage CO
    Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.